Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study.Literature -Buse JB, Nau
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION6): a randomised, openlabel study.

As we can see from the illustration, Liraglutide Vs Exenatide has many fascinating aspects to explore.
Not FDA-approved for obesity. Weight loss is secondary benefit only. LEAD-6 head-to-head showed 2.87 kg loss with exenatide vs 3.24 kg with liraglutide at 26 weeks.

Conclusions: Liraglutide 1.2 mg provided a statistically significantly greater reduction in HbA1c than exenatide 10 g BID. The significantly shorter duration of nausea with liraglutide vs...

This particular example perfectly highlights why Liraglutide Vs Exenatide is so captivating.
Exenatide vs Liraglutide compare dosing, benefits, safety profiles, side effects, and how they stack.
Economic outcomes of exenatide vs liraglutide in type 2 diabetes patients in the United States: results from a retrospective claims database analysis. J Med Econ. 2012; 15: 1039-1050.